Table 5—

Response duration, time to progression and survival

PatientsWeeks
Response duration
 All2413.6 (3.0–47.9)
 Platinum +PT1612.1 (3.0–47.9)#
 Platinum -PT819.4 (7.3–40.9)
 Sensitive1915.0 (3.0–47.9)
 Refractory513.0 (4.7–27.1)
Time to progression
 All1648.0 (0.1–53.6)
 Platinum +PT1047.9 (2.1–53.6)+
 Platinum -PT609.6 (0.1–48.0)
 Sensitive1078.0 (2.1–53.6)§
 Refractory579.6 (0.1–41.3)
Survival
 All16423.4 (0.9–92.4)
 Platinum +PT10423.4 (0.9–92.4)ƒ
 Platinum -PT6022.9 (1.1–83.1)
 Sensitive10722.4 (0.9–92.4)##
 Refractory5723.7 (1.1–85.7)
  • Data are presented as n or median (interquartile range). Platinum +PT: platinum-containing pre-treatment; Platinum -PT: platinum-free pre-treatment. #: p = 0.372 platinum +PT versus platinum -PT; : p = 0.339 sensitive versus refractory; +: p = 0.017 platinum +PT versus platinum -PT; §: p = 0.472 sensitive versus refractory; ƒ: p = 0.878 platinum +PT versus platinum -PT; ##: p = 0.82 sensitive versus refractory.